Guard Therapeutics International AB (publ) reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was SEK 39.92 million compared to SEK 18.98 million a year ago. Basic loss per share from continuing operations was SEK 4 compared to SEK 3 a year ago.